1 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 1)* UNIVERSAL HEALTH SERVICES, INC. ---------------------------------------------------------------- (Name of Issuer) Class B Common Stock, $.01 Par Value ---------------------------------------------------------------- (Title of Class of Securities) 913903100 ----------------------------- (CUSIP Number) Stephen M. Vine, Esq. Akin, Gump, Strauss, Hauer & Feld, L.L.P. 65 East 55th Street, 33rd Floor New York, New York 10022 (212) 872-1000 ----------------------------------------- (Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications) June 28, 1994 --------------------------------------- (Date of Event which Requires Filing of this Statement) If the filing person has previously filed a statement on Schedule 13G to report the acquisition which is the subject of this Schedule 13D, and is filing this schedule because of Rule 13d-1(b)(3) or (4), check the following box / /. Check the following box if a fee is being paid with the statement / /. (A fee is not required only if the reporting person: (1) has a previous statement on file reporting beneficial ownership of more than five percent of the class of securities described in Item 1; and (2) has filed no amendment subsequent thereto reporting beneficial ownership of five percent or less of such class.) (See Rule 13d-7) Note: Six copies of this statement, including all exhibits, should be filed with the Commission. See Rule 13d-1(a) for other parties to whom copies are to be sent. *The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosure provided in a prior cover page. The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). Continued on following page(s) Page 1 of 6 Pages Exhibit Index: None 2 SCHEDULE 13D CUSIP NO. 913903100 PAGE 2 OF 6 PAGES 1 Name of Reporting Person S.S. or I.R.S. Identification No. of Above Person GEORGE SOROS (doing business as SOROS FUND MANAGEMENT) 2 Check the Appropriate Box If a Member of a Group* a. / / b. / / 3 SEC Use Only 4 Source of Funds* AF 5 Check Box If Disclosure of Legal Proceedings Is Required Pursuant to Items 2(d) or 2(e) / / 6 Citizenship or Place of Organization UNITED STATES 7 Sole Voting Power Number of 866,100 Shares Beneficially 8 Shared Voting Power Owned By 0 Each Reporting 9 Sole Dispositive Power Person 866,100 With 10 Shared Dispositive Power 0 11 Aggregate Amount Beneficially Owned by Each Reporting Person 866,100 12 Check Box If the Aggregate Amount in Row (11) Excludes Certain Shares* / / 13 Percent of Class Represented By Amount in Row (11) 6.5% 14 Type of Reporting Person* IA; IN *SEE INSTRUCTIONS BEFORE FILLING OUT! 3 Page 3 ITEM 1. SECURITY AND ISSUER. This Amendment No. 1 to Schedule 13D relates to shares (the "Shares") of Class B Common Stock, $.01 par value, of Universal Health Services, Inc. (the "Issuer"). The address of the principal executive offices of the Issuer is 367 South Gulph Road, King of Prussia, Pennsylvania 19406. This Amendment No. 1 amends the initial statement on Schedule 13D (the "Initial Statement") filed on May 19, 1994 by Mr. George Soros, doing business as Soros Fund Management (the "Reporting Person"). Reference is made to the Initial Statement for information concerning certain defined terms used herein and not otherwise defined herein. ITEM 2. SOURCE AND AMOUNT OF FUNDS OR OTHER CONSIDERATION. Quasar Partners expended $3,328,169 of its working capital to purchase the Shares which are reported in Item 5(c) as having been purchased for its account since May 19, 1994, the date of the most recent filing on Schedule 13D. The Shares held by the SFM Clients were purchased through margin accounts maintained for each of them with Arnhold and S. Bleichroeder, Inc., which extends margin credit to the SFM Clients as and when required to open or carry positions in their respective margin accounts, subject to applicable Federal margin regulations, stock exchange rules and the firm's credit policies. The positions held in the margin accounts, including the Shares, are pledged as collateral security for the repayment of debit balances in the respective accounts. ITEM 3. PURPOSE OF TRANSACTION. The Reporting Person acquired the Shares for the account of the SFM Clients for investment purposes, and the Reporting Person does not have any present plans or proposals that relate to or would result in any change in the business, policies, management, structure or capitalization of the Issuer. The Reporting Person reserves the right to acquire additional securities of the Issuer, to dispose of such securities at any time or to formulate other purposes, plans or proposals regarding the Issuer or any of its securities, to the extent deemed advisable in light of its general investment and trading policies, market conditions or other factors. The Reporting Person is interested in pursuing discussions with management of the Issuer regarding methods to realize shareholder value, which management has stated is an important goal. ITEM 4. INTEREST IN SECURITIES OF THE ISSUER. (a) The Reporting Person may be deemed the beneficial owner of 866,100 Shares (approximately 6.5% of the total number of Shares outstanding). This number consists of (i) 475,100 Shares held for the account of Quantum Partners (approximately 3.6% of the total number of Shares outstanding) and (ii) 391,000 Shares held for the account of Quasar Partners (approximately 2.9% of the total number of Shares outstanding). Mr. Soros, as sole proprietor of SFM, may be considered a beneficial owner of the Shares held for the account of the SFM Clients by reason of the SFM Contracts with the SFM Clients for the purposes of Section 13(d) of the 1934 Act. (b) SFM exercises the sole power to direct the disposition and voting of the 475,100 Shares held for the account of Quantum Partners and the 391,000 Shares held for the account of Quasar Partners. 4 Page 4 (c) A schedule identifying all transactions involving the Shares effected by the Reporting Person since May 19, 1994 (the date of the most recent filing in Schedule 13D) is included as Annex A hereto which is incorporated by reference in response to this Item 5(c). Each of the transactions was executed in conventional brokerage transactions in the over-the-counter market. Except for the transactions listed in Annex A, there have been no transactions with respect to the Shares since May 19, 1994, the date of the most recent filing in Schedule 13D, by the Reporting Person or other persons identified in response to Item 2. ITEM 5. MATERIAL TO BE FILED AS EXHIBITS. (a) Power of Attorney, dated December 11, 1991, granted by Mr. George Soros in favor of Mr. Sean C. Warren (filed as Exhibit A to the Initial Statement and incorporated herein by reference). 5 Page 5 SIGNATURES After reasonable inquiry and to the best of my knowledge and belief, the undersigned certifies that the information set forth in this statement is true, complete and correct. Date: June 29, 1994 GEORGE SOROS By: /s/ Sean C. Warren -------------------------- Sean C. Warren Attorney-in-Fact 6 Page 6 ANNEX A RECENT TRANSACTIONS IN COMMON STOCK OF UNIVERSAL HEALTH SERVICES, INC. - ------------------------ (1) Transactions effected at the direction of Soros Fund Management
For the Account of Date of Transaction Nature of Transaction Number of Shares Price per Share($) - ------------------ ------------------- --------------------- ---------------- ----------------- Quasar International 5/19/94 Purchase 600 25.675 Partners C.V.(1) 5/20/94 Purchase 18,000 26.043 5/23/94 Purchase 1,400 25.675 5/26/94 Purchase 900 25.050 6/27/94 Purchase 10,000 26.050 6/28/94 Purchase 100,000 25.250